银屑病性疾病中的动脉粥样硬化：最新证据及临床意义
Atherosclerosis in psoriatic disease: latest evidence and clinical implications.
作者信息
Eder Lihi, Gladman Dafna D
机构信息
Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada.
Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst St. 1E-410B, Toronto, Ontario, Canada M5T 2S8.
出版信息
Ther Adv Musculoskelet Dis. 2015 Oct;7(5):187-95. doi: 10.1177/1759720X15591801.
Abstract
It is widely accepted that atherosclerosis is caused by chronic low-grade inflammation that results from an interaction between immune mechanisms and metabolic abnormalities within the vessel wall. Population-based studies have found an increased cardiovascular risk in patients with psoriasis and psoriatic arthritis (PsA). This risk is higher in patients with severe disease phenotypes, such as those with severe psoriasis and with musculoskeletal inflammation. Higher levels of inflammatory biomarkers also predict the development of clinical cardiovascular events in these patients. The effect of medications used for PsA on cardiovascular risk is limited to observational studies. Antitumor necrosis factor agents and methotrexate have been associated with reduced cardiovascular risk. These data highlight the importance of screening for cardiovascular risk factors in these patients.
摘要
普遍认为，动脉粥样硬化是由血管壁内免疫机制与代谢异常相互作用导致的慢性低度炎症引起的。基于人群的研究发现，银屑病和银屑病关节炎（PsA）患者的心血管风险增加。在患有严重疾病表型的患者中，如重度银屑病和肌肉骨骼炎症患者，这种风险更高。较高水平的炎症生物标志物也可预测这些患者临床心血管事件的发生。用于治疗PsA的药物对心血管风险的影响仅限于观察性研究。抗肿瘤坏死因子药物和甲氨蝶呤与降低心血管风险有关。这些数据凸显了在这些患者中筛查心血管危险因素的重要性。
相似文献
1
Atherosclerosis in psoriatic disease: latest evidence and clinical implications.银屑病性疾病中的动脉粥样硬化：最新证据及临床意义
Ther Adv Musculoskelet Dis. 2015 Oct;7(5):187-95. doi: 10.1177/1759720X15591801.
2
Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis.银屑病和银屑病关节炎的心脏代谢合并症。
Int J Mol Sci. 2017 Dec 25;19(1):58. doi: 10.3390/ijms19010058.
3
Cardiometabolic Disorders in Psoriatic Disease.银屑病中的心脏代谢紊乱
Curr Rheumatol Rep. 2017 Aug 26;19(10):63. doi: 10.1007/s11926-017-0692-2.
4
The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.肿瘤坏死因子抑制剂、甲氨蝶呤、非甾体抗炎药和皮质类固醇对类风湿关节炎、银屑病和银屑病关节炎患者心血管事件的影响：一项系统评价和荟萃分析。
Ann Rheum Dis. 2015 Mar;74(3):480-9. doi: 10.1136/annrheumdis-2014-206624. Epub 2015 Jan 5.
5
Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review.银屑病和银屑病关节炎的心血管发病率和死亡率：系统文献回顾。
J Eur Acad Dermatol Venereol. 2013 Aug;27 Suppl 3:12-29. doi: 10.1111/jdv.12163.
6
[Cardiovascular risk in patients with psoriatic arthritis].[银屑病关节炎患者的心血管风险]
Ter Arkh. 2016;88(5):102-106. doi: 10.17116/terarkh2016885102-106.
7
Psoriasis and atherosclerosis: Is there a need for novel biomarkers assessing cardiovascular risk?银屑病与动脉粥样硬化：是否需要新型生物标志物来评估心血管风险？
Curr Pharm Des. 2014;20(4):529-35. doi: 10.2174/138161282004140213124141.
8
Increased burden of inflammation over time is associated with the extent of atherosclerotic plaques in patients with psoriatic arthritis.随着时间的推移，炎症负担的增加与银屑病关节炎患者动脉粥样硬化斑块的程度有关。
Ann Rheum Dis. 2015 Oct;74(10):1830-5. doi: 10.1136/annrheumdis-2014-205267. Epub 2014 May 14.
9
Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients.银屑病关节炎患者的心血管风险标志物与主要不良心血管事件
Rev Recent Clin Trials. 2018;13(3):199-209. doi: 10.2174/1574887113666180314105511.
10
Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis.银屑病关节炎患者亚临床动脉粥样硬化的生物标志物
Open Access Rheumatol. 2019 Jun 28;11:143-156. doi: 10.2147/OARRR.S206931. eCollection 2019.
引用本文的文献
1
Prevalence of metabolic syndrome and its components in psoriatic arthritis compared with general population, cutaneous psoriasis, and other inflammatory arthropathies: a meta-analysis.与普通人群、皮肤银屑病及其他炎性关节病相比，银屑病关节炎中代谢综合征及其组分的患病率：一项荟萃分析。
Clin Rheumatol. 2025 Aug 18. doi: 10.1007/s10067-025-07637-z.
2
Association of the Monocyte-to-High Density Lipoprotein Ratio with the FRS and as a Predictor of Cardiovascular Risk in Individuals with Psoriasis Vulgaris.寻常型银屑病患者单核细胞与高密度脂蛋白比值与弗雷明汉风险评分的关联及作为心血管风险预测指标的研究
Clin Cosmet Investig Dermatol. 2025 May 1;18:1051-1062. doi: 10.2147/CCID.S518521. eCollection 2025.
3
The metabolic score for insulin resistance predicts the risk of cardiovascular disease in patients with psoriatic arthritis: results from the 10-year prospective CARMA cohort.胰岛素抵抗代谢评分可预测银屑病关节炎患者的心血管疾病风险：来自为期10年的前瞻性CARMA队列研究的结果
RMD Open. 2025 Mar 7;11(1):e005352. doi: 10.1136/rmdopen-2024-005352.
4
Metabolic Syndrome and Its Components in Psoriatic Arthritis.银屑病关节炎中的代谢综合征及其组成部分
Open Access Rheumatol. 2022 Feb 17;14:7-16. doi: 10.2147/OARRR.S347797. eCollection 2022.
5
Prevalence and Extent of Subclinical Atherosclerosis and Associated Cardiovascular Risk Factors in Adult Patients With Psoriatic Arthritis: A Systematic Review.银屑病关节炎成年患者亚临床动脉粥样硬化的患病率、程度及相关心血管危险因素：一项系统评价
Cureus. 2021 Aug 3;13(8):e16853. doi: 10.7759/cureus.16853. eCollection 2021 Aug.
6
Trimethylamine N-Oxide, a Gut Microbiota-Derived Metabolite, Is Associated with Cardiovascular Risk in Psoriasis: A Cross-Sectional Pilot Study.氧化三甲胺，一种源自肠道微生物群的代谢产物，与银屑病患者的心血管风险相关：一项横断面初步研究。
Dermatol Ther (Heidelb). 2021 Aug;11(4):1277-1289. doi: 10.1007/s13555-021-00547-3. Epub 2021 May 13.
7
Therapeutic wavelengths of ultraviolet B radiation activate apoptotic, circadian rhythm, redox signalling and key canonical pathways in psoriatic epidermis.紫外线B辐射的治疗波长可激活银屑病表皮中的凋亡、昼夜节律、氧化还原信号传导及关键经典通路。
Redox Biol. 2021 May;41:101924. doi: 10.1016/j.redox.2021.101924. Epub 2021 Mar 10.
8
Cardiovascular Risk in Patients With Psoriasis: JACC Review Topic of the Week.银屑病患者的心血管风险：JACC 本周综述主题。
J Am Coll Cardiol. 2021 Apr 6;77(13):1670-1680. doi: 10.1016/j.jacc.2021.02.009.
9
Application of machine learning in understanding atherosclerosis: Emerging insights.机器学习在理解动脉粥样硬化中的应用：新见解
APL Bioeng. 2021 Feb 16;5(1):011505. doi: 10.1063/5.0028986. eCollection 2021 Mar.
10
Changes in metabolic parameters in psoriatic patients treated with secukinumab.接受司库奇尤单抗治疗的银屑病患者代谢参数的变化。
Ther Adv Chronic Dis. 2020 Aug 3;11:2040622320944777. doi: 10.1177/2040622320944777. eCollection 2020.
本文引用的文献
1
Investigation of subclinical atherosclerosis in psoriatic arthritis patients with minimal disease activity.对疾病活动度极低的银屑病关节炎患者亚临床动脉粥样硬化的调查。
Rheumatol Int. 2015 Aug;35(8):1385-92. doi: 10.1007/s00296-015-3228-y. Epub 2015 Feb 11.
2
Comprehensive treatment of psoriatic arthritis: managing comorbidities and extraarticular manifestations.银屑病关节炎的综合治疗：合并症及关节外表现的管理
J Rheumatol. 2014 Nov;41(11):2315-22. doi: 10.3899/jrheum.140882.
3
Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study.患有银屑病关节炎、银屑病和类风湿关节炎患者的主要心血管事件风险：一项基于人群的队列研究。
Ann Rheum Dis. 2015 Feb;74(2):326-32. doi: 10.1136/annrheumdis-2014-205675. Epub 2014 Oct 28.
4
Interleukin 17 drives vascular inflammation, endothelial dysfunction, and arterial hypertension in psoriasis-like skin disease.白细胞介素 17 驱动银屑病样皮肤疾病中的血管炎症、内皮功能障碍和动脉高血压。
Arterioscler Thromb Vasc Biol. 2014 Dec;34(12):2658-68. doi: 10.1161/ATVBAHA.114.304108. Epub 2014 Oct 23.
5
Cardiovascular outcomes and systemic anti-inflammatory drugs in patients with severe psoriasis: 5-year follow-up of a Danish nationwide cohort.严重银屑病患者的心血管结局和全身抗炎药物：丹麦全国队列的 5 年随访。
J Eur Acad Dermatol Venereol. 2015 Jun;29(6):1128-34. doi: 10.1111/jdv.12768. Epub 2014 Oct 10.
6
Accumulating evidence for the association and shared pathogenic mechanisms between psoriasis and cardiovascular-related comorbidities.越来越多的证据表明银屑病与心血管相关合并症之间存在关联及共同的致病机制。
Am J Med. 2014 Dec;127(12):1148-53. doi: 10.1016/j.amjmed.2014.08.008. Epub 2014 Aug 19.
7
Tumor necrosis factor inhibitor therapy and myocardial infarction risk in patients with psoriasis, psoriatic arthritis, or both.
J Drugs Dermatol. 2014 Aug;13(8):932-4.
8
Psoriatic arthritis and sacroiliitis are associated with increased vascular inflammation by 18-fluorodeoxyglucose positron emission tomography computed tomography: baseline report from the Psoriasis Atherosclerosis and Cardiometabolic Disease Initiative.银屑病关节炎和骶髂关节炎与通过18-氟脱氧葡萄糖正电子发射断层扫描计算机断层扫描显示的血管炎症增加相关：来自银屑病动脉粥样硬化和心脏代谢疾病倡议的基线报告。
Arthritis Res Ther. 2014 Jul 30;16(4):R161. doi: 10.1186/ar4676.
9
Increased burden of inflammation over time is associated with the extent of atherosclerotic plaques in patients with psoriatic arthritis.随着时间的推移，炎症负担的增加与银屑病关节炎患者动脉粥样硬化斑块的程度有关。
Ann Rheum Dis. 2015 Oct;74(10):1830-5. doi: 10.1136/annrheumdis-2014-205267. Epub 2014 May 14.
10
Atherosclerosis progression in psoriatic arthritis patients despite the treatment with tumor necrosis factor-alpha blockers: a two-year prospective observational study.尽管使用肿瘤坏死因子-α阻滞剂治疗，银屑病关节炎患者的动脉粥样硬化仍在进展：一项为期两年的前瞻性观察研究。
Joint Bone Spine. 2014 Oct;81(5):421-5. doi: 10.1016/j.jbspin.2014.02.005. Epub 2014 Apr 2.
Zotero 插件